Market Tracker

02/16 5:15pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

120.47
Delayed Data
As of Feb 16
 -2.24 / -1.83%
Today’s Change
96.18
Today|||52-Week Range
149.34
+0.74%
Year-to-Date

Today’s Trading

Previous close122.71
Today’s open122.57
Day’s range119.24 - 123.17
Volume3,898,513
Average volume (3 months)2,188,371
Market cap$26.7B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+11.93%
Earnings growth (this year)--
Earnings growth (next 5 years)+18.53%
Revenue growth (last year)+17.32%
P/E ratio61.2
Price/Sales7.63
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.23+1.57%
BAXBaxter International...-0.11-0.17%
INCYIncyte Corp+0.44+0.51%
VRTXVertex Pharmaceutica...-0.22-0.14%
Data as of 4:15pm ET, 02/16/2018

Financials

Last reporting dateFebruary 8, 2018
EPS forecast (this quarter)$1.27
Annual revenue (last year)$3.5B
Annual profit (last year)$443.3M
Net profit margin12.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts